How to Get Testosterone Enanthate in South Carolina

South Carolina Prescribing Laws for Testosterone Enanthate

Testosterone enanthate is classified as a Schedule III controlled substance under both federal law and the South Carolina Code of Laws, Title 44, Chapter 53. Any prescriber holding a valid DEA registration and an active South Carolina medical license may write a prescription for it. This includes MDs, DOs, nurse practitioners with full practice authority, and physician assistants operating under a supervising physician's scope agreement.

South Carolina granted NPs full practice authority effective January 1, 2024, removing the prior requirement for a collaborative practice agreement after 5 to 000 hours of clinical experience. This change expanded access to TRT prescribing in rural counties where physician density is low. The state had just 6.3 active primary care physicians per 10,000 population in 2021, well below the national median of 7.6, making NP prescribing a practical necessity for many patients [1].

A prescriber must document a clinical indication. The Endocrine Society 2018 Clinical Practice Guideline recommends testosterone therapy only for men with "unequivocally low serum testosterone concentrations" confirmed on at least two morning samples, combined with signs and symptoms of androgen deficiency [2]. South Carolina law does not impose state-specific diagnostic criteria beyond what federal scheduling requires: a legitimate medical purpose and a bona fide prescriber-patient relationship.

Telehealth Access in South Carolina

South Carolina permits prescribing testosterone enanthate through telehealth. The SC Board of Medical Examiners allows synchronous audio-video consultations to establish a prescriber-patient relationship, and the state has no separate in-person requirement for controlled substances when prescribed via a DEA-registered telehealth platform.

Post-pandemic telehealth utilization in South Carolina remains significantly above pre-2020 baselines. A 2023 CDC analysis found that 37.0% of U.S. adults had used telehealth in the prior 12 months, with southern states showing the fastest growth in adoption [3]. For testosterone prescribing specifically, telehealth has closed geographic gaps in counties like Allendale, Hampton, and Bamberg, where no board-certified endocrinologist practices locally.

The typical telehealth workflow looks like this: you complete an intake questionnaire, upload recent lab results or receive an order for bloodwork at a local draw site (LabCorp and Quest both operate extensively across SC), then attend a video consultation. If you meet diagnostic criteria, the prescriber sends an electronic prescription to your chosen pharmacy. Most patients receive their medication within 7 to 14 days of first contact.

Required Labs Before Starting Testosterone Enanthate

No responsible prescriber will write a testosterone enanthate prescription without baseline bloodwork. The Endocrine Society guideline specifies a minimum panel that includes total testosterone drawn between 7:00 and 10:00 AM on two separate days, because levels fluctuate with circadian rhythm and can vary by 20 to 30% within an individual [2].

Beyond the confirmatory testosterone draws, a standard pre-TRT panel in South Carolina typically includes:

• Complete blood count (CBC) to establish baseline hematocrit. The T-Trials (NEJM 2016, N=790) demonstrated that testosterone treatment increased hemoglobin by a mean of 0.58 g/dL at 12 months versus placebo, so monitoring hematocrit is essential to detect polycythemia early [4].
• Comprehensive metabolic panel (CMP) for liver and kidney function.
• Lipid panel, since testosterone can reduce HDL cholesterol.
• PSA (prostate-specific antigen) in men aged 40 and older, per AUA/Endocrine Society recommendations [2].
• LH and FSH to differentiate primary from secondary hypogonadism.
• Estradiol (sensitive assay) for baseline aromatization reference.

A total testosterone level below 300 ng/dL on two morning draws is the most widely used diagnostic threshold. The American Urological Association (AUA) states that "clinicians should use a total testosterone level below 300 ng/dL as a reasonable cut-off in support of a diagnosis of low testosterone" [2]. Some prescribers also assess free testosterone by equilibrium dialysis when SHBG levels are borderline or when total testosterone falls between 250 and 400 ng/dL.

Pharmacies and 503A Compounding in South Carolina

Once you have a prescription, you can fill it at any SC-licensed retail pharmacy or a 503A compounding pharmacy. Both routes are legal. The choice depends on cost, insurance status, and personal preference.

Brand-name testosterone enanthate (Delatestryl) and generic formulations are stocked at major chains including CVS, Walgreens, and Publix pharmacy locations across South Carolina. GoodRx estimates place the cash price for a 5 mL vial of testosterone enanthate 200 mg/mL between $40 and $90 at SC retail pharmacies without insurance.

503A compounding pharmacies operate under section 503A of the Federal Food, Drug, and Cosmetic Act and must hold a South Carolina Board of Pharmacy compounding permit [5]. These pharmacies may prepare patient-specific testosterone enanthate prescriptions in customized concentrations (commonly 200 mg/mL in grapeseed or cottonseed oil) and ship within the state. They cannot distribute across state lines without a 503B outsourcing facility registration.

Several SC-based 503A pharmacies offer testosterone enanthate at prices between $30 and $60 per month for a standard 200 mg/mL weekly protocol, often including bacteriostatic water and syringes. The prescriber must include the specific patient name on the prescription; 503A pharmacies cannot fill "office use" orders.

Insurance Coverage and Prior Authorization in South Carolina

Commercial insurance plans in South Carolina generally cover testosterone enanthate for male hypogonadism when prior authorization criteria are met. South Carolina Medicaid, however, does not cover testosterone enanthate for this indication.

Prior authorization documentation typically requires:

• Two morning serum testosterone levels below the lab reference range (most plans use 300 ng/dL)
• Documentation of clinical symptoms (fatigue, reduced libido, erectile dysfunction, decreased bone mineral density)
• Confirmation that the condition is not caused by a reversible etiology that should be treated first
• A note indicating whether the patient has primary or secondary hypogonadism

BlueCross BlueShield of South Carolina, the state's largest commercial insurer, covers injectable testosterone enanthate on its formulary when prior authorization is approved. Turn-around time for PA decisions in SC ranges from 24 to 72 hours under state prompt-pay regulations. If denied, patients may file an appeal with supporting lab documentation.

For patients paying out of pocket, whether due to Medicaid exclusion or high-deductible plans, manufacturer discount programs and compounding pharmacies offer the most affordable paths. The cost difference is significant: a commercially insured copay may run $10 to $30 per month, while cash-pay retail runs $40 to $90 and compounding runs $30 to $60.

Dosing, Administration, and Follow-Up Protocol

The FDA-approved prescribing information for testosterone enanthate specifies a dose range of 50 to 400 mg administered intramuscularly every 2 to 4 weeks for male hypogonadism [6]. In practice, most TRT clinicians now prefer 100 to 200 mg once weekly or split into twice-weekly injections to reduce peak-trough fluctuations.

Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School and author of the foundational text on modern TRT, has written that "the goal of testosterone therapy is to restore serum testosterone concentrations to the mid-normal range, not to achieve supraphysiological levels" [7]. This principle guides the standard South Carolina prescribing approach: start low, titrate based on symptom response and repeat labs at 8 to 12 weeks.

The first follow-up lab draw should occur at approximately 8 to 12 weeks after initiation and should include:

• Trough total testosterone (drawn the morning before the next injection)
• CBC with hematocrit (target hematocrit below 54%)
• PSA in men over 40

The Endocrine Society recommends monitoring at 3 months, 6 months, and then annually [2]. If hematocrit exceeds 54%, the guideline advises dose reduction, therapeutic phlebotomy, or temporary cessation. A 2019 meta-analysis in JAMA Internal Medicine (N=3,431) found that testosterone therapy was associated with an increase in hematocrit of 3.2 percentage points compared with placebo, making this the most common lab abnormality requiring intervention [8].

Transferring a Prescription to South Carolina

If you are relocating to South Carolina from another state and already have an active testosterone enanthate prescription, any SC-licensed pharmacy can accept an interstate prescription transfer. Because testosterone enanthate is a Schedule III controlled substance, the transfer must follow DEA regulations: only one transfer is permitted between pharmacies, and the original dispensing pharmacy must communicate directly with the receiving pharmacy.

Telehealth platforms that operate in both your origin state and South Carolina can simplify this process. Rather than transferring, the prescriber can issue a new prescription to an SC pharmacy using your existing medical records and lab history. This approach avoids the one-transfer limitation and keeps your care continuity intact.

The South Carolina Board of Pharmacy requires that all controlled substance prescriptions, including transfers, be verified through the state's Prescription Drug Monitoring Program (PDMP). Prescribers and pharmacists must check the PDMP before dispensing, per SC Code Section 44-130-60.

What to Expect After Starting Testosterone Enanthate

Symptom improvement follows a predictable timeline documented in a 2011 review published in the European Journal of Endocrinology [9]. Libido and energy improvements typically appear within 3 to 6 weeks. Changes in body composition (increased lean mass, decreased fat mass) become measurable at 12 to 16 weeks. Mood and depressive symptoms may begin to improve within 3 to 6 weeks, with maximum effect at 18 to 30 weeks.

The T-Trials, a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older with testosterone levels below 275 ng/dL, found statistically significant improvements in sexual activity scores (effect size 0.45, P<0.001), physical activity (walking distance increased by a mean of 6.0 meters in the 6-minute walk test), and mood (PHQ-9 score improvement of 1.4 points, P=0.004) at 12 months of testosterone gel treatment [4]. These findings, while derived from gel formulations, are considered applicable to enanthate given equivalent steady-state serum concentrations.

Not every patient responds identically. The Endocrine Society notes that "if there is no symptomatic improvement after a reasonable trial period (typically 6 to 12 months), testosterone therapy should be discontinued" [2].